FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Smith Martin Dewayne 		2. Issuer Name and Ticker or Trading Symbol

Quorum Health Corp [ QHC ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
EVP & Chief Operating Officer
(Last)          (First)          (Middle)

1573 MALLORY LANE, SUITE 100 		3. Date of Earliest Transaction (MM/DD/YYYY)

3/1/2017
(Street)

BRENTWOOD, TN 37027
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, par value $0.0001 per share   3/1/2017     F    772   D $8.52   200944   D    
Common stock, par value $0.0001 per share   2/22/2018     F    2471   D $6.16   198473   D    
Common stock, par value $0.0001 per share   3/1/2018     F    865   D $5.68   197608   D    
Common stock, par value $0.0001 per share   5/3/2018     F    6900   D $7.41   190708   D    
Common stock, par value $0.0001 per share   2/22/2019     F    8249   D $2.54   182459   D    
Common stock, par value $0.0001 per share   3/9/2019     F    2471   D $2.35   179988   D    
Common stock, par value $0.0001 per share   5/3/2019     F    6900   D $1.98   173088   D    
Common stock, par value $0.0001 per share   5/31/2019     A    140000   (1) A $0.00   313088   D    
Common stock, par value $0.0001 per share   5/31/2019     A    75000   (2) A $0.00   388088   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
(1)  On May 31, 2019, the reporting person received a grant of 140,000 shares of restricted common stock pursuant to the Quorum Health Corporation 2018 Restricted Stock Plan. 100% of the number of shares of restricted stock are subject to a vesting cliff that lapses on December 17, 2020.
(2)  On May 31, 2019, the reporting person received a grant of 75,000 shares of restricted common stock pursuant to the Quorum Health Corporation Amended and Restated 2016 Stock Award Plan. 50% of the award is time-vested restricted stock and vests in three annual equal installments beginning on February 14, 2020, and 50% of the award is performance-based restricted common stock and vests, if at all, over a two-year performance period based on the achievement of certain performance criteria.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Smith Martin Dewayne
1573 MALLORY LANE
SUITE 100
BRENTWOOD, TN 37027

EVP & Chief Operating Officer

Signatures
/s/ Ray Harold McCard, Jr., Attorney in Fact for Martin Dewayne Smith 6/4/2019
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Quorum Health Charts.
Quorum Health (NYSE:QHC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Quorum Health Charts.